Literature DB >> 17346585

Bisphosphonate treatment: an orthodontic concern calling for a proactive approach.

James J Zahrowski1.   

Abstract

The purpose of this article is to raise awareness among orthodontists of the effects of bisphosphonates, a commonly prescribed type of drug that can inhibit tooth movement and increase serious osteonecrosis risks in the alveolar bones of the maxilla and the mandible. Common medical uses of bisphosphonates, applicable pharmacology, pharmacokinetics, reports of impaired bone healing and induced osteonecrosis, and a drug effect accumulation theory are reviewed. Potential orthodontic issues and proposed orthodontic recommendations for intravenous and oral bisphosphonate treatments are discussed. Bisphosphonate medication screening, patient counseling, informed consent, and, perhaps, changes in treatment planning might be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346585     DOI: 10.1016/j.ajodo.2006.09.035

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  11 in total

1.  [Orthodontic treatment of patients medicated with bisphosphonates-a clinical case report].

Authors:  Elena Krieger; Bernd d'Hoedt; Herbert Scheller; Collin Jacobs; Christian Walter; Heinrich Wehrbein
Journal:  J Orofac Orthop       Date:  2013-01       Impact factor: 1.938

Review 2.  Effect of bisphosphonates on orthodontic tooth movement-an update.

Authors:  Sindhuja Krishnan; Saravana Pandian; Aravind Kumar S
Journal:  J Clin Diagn Res       Date:  2015-04-01

3.  Impact of Bisphosphonate on Orthodontic tooth movement and osteoclastic count: An Animal Study.

Authors:  V Venkataramana; S Chidambaram; B Vishnuvardhan Reddy; E V Soma Shekara Goud; Mohammed Arafath; Santhana Krishnan6
Journal:  J Int Oral Health       Date:  2014-04-26

4.  Modulation of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments.

Authors:  M-Y Chou; D Yan; T Jafarov; E T Everett
Journal:  Orthod Craniofac Res       Date:  2009-05       Impact factor: 1.826

5.  Effect of zoledronic acid on bone healing subsequent to mini-implant insertion.

Authors:  Sarandeep S Huja; Burçak Kaya; X Mo; Andrew M D'Atri; Soledad A Fernandez
Journal:  Angle Orthod       Date:  2011-01-24       Impact factor: 2.079

Review 6.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

7.  Effect of local injection of Zolena, zoledronic acid made in Iran, on orthodontic tooth movement and root and bone resorption in rats.

Authors:  Massoud Seifi; Sohrab Asefi; Ghazal Hatamifard; Ali Lotfi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2017-12-13

Review 8.  Current state of orthodontic patients under bisphosphonate therapy.

Authors:  Elena Krieger; Collin Jacobs; Christian Walter; Heinrich Wehrbein
Journal:  Head Face Med       Date:  2013-04-04       Impact factor: 2.151

9.  Bisphosphonate-Related Osteonecrosis of the Jaw Bone: Radiological Pattern and the Potential Role of CBCT in Early Diagnosis.

Authors:  James Olutayo; Jimoh Olubanwo Agbaje; Reinhilde Jacobs; Vicky Verhaeghe; Filip Vande Velde; Frans Vinckier
Journal:  J Oral Maxillofac Res       Date:  2010-07-01

10.  Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment.

Authors:  V Venkataramana; S Sathesh Kumar; B Vishnuvardhan Reddy; A Sreekanth Cherukuri; K Raja Sigamani; G Chandrasekhar
Journal:  J Pharm Bioallied Sci       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.